ES2136615T3 - Nuevos inhibidores de glucohidrolasa utiles como agentes antidiabeticos, antiviricos y antimetastasicos. - Google Patents

Nuevos inhibidores de glucohidrolasa utiles como agentes antidiabeticos, antiviricos y antimetastasicos.

Info

Publication number
ES2136615T3
ES2136615T3 ES92904197T ES92904197T ES2136615T3 ES 2136615 T3 ES2136615 T3 ES 2136615T3 ES 92904197 T ES92904197 T ES 92904197T ES 92904197 T ES92904197 T ES 92904197T ES 2136615 T3 ES2136615 T3 ES 2136615T3
Authority
ES
Spain
Prior art keywords
glucohidrolase
antiviric
antimetastasic
antidiabetic
inhibitors
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES92904197T
Other languages
English (en)
Inventor
Robert A Farr
Norton P Peet
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aventis Pharmaceuticals Inc
Original Assignee
Merrell Dow Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Dow Pharmaceuticals Inc filed Critical Merrell Dow Pharmaceuticals Inc
Application granted granted Critical
Publication of ES2136615T3 publication Critical patent/ES2136615T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D339/00—Heterocyclic compounds containing rings having two sulfur atoms as the only ring hetero atoms
    • C07D339/08—Six-membered rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C215/00—Compounds containing amino and hydroxy groups bound to the same carbon skeleton
    • C07C215/42—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having amino groups or hydroxy groups bound to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
    • C07C215/44—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having amino groups or hydroxy groups bound to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton bound to carbon atoms of the same ring or condensed ring system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/56—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds from heterocyclic compounds
    • C07C45/567—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds from heterocyclic compounds with sulfur as the only hetero atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C47/00—Compounds having —CHO groups
    • C07C47/20—Unsaturated compounds having —CHO groups bound to acyclic carbon atoms
    • C07C47/277—Unsaturated compounds having —CHO groups bound to acyclic carbon atoms containing ether groups, groups, groups, or groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
    • C07D261/20—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings condensed with carbocyclic rings or ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/12—Systems containing only non-condensed rings with a six-membered ring

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Transceivers (AREA)
  • Mobile Radio Communication Systems (AREA)

Abstract

SE DESCRIBEN UNOS NUEVOS INHIBIDORES DE ALFA GLUCOHIDROLASA UTILES EN EL TRATAMIENTO DE INFECCIONES VIRICAS Y TUMORES METASTATICOS.
ES92904197T 1991-01-10 1991-12-13 Nuevos inhibidores de glucohidrolasa utiles como agentes antidiabeticos, antiviricos y antimetastasicos. Expired - Lifetime ES2136615T3 (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US63963591A 1991-01-10 1991-01-10
US78420891A 1991-10-28 1991-10-28
PCT/US1991/009387 WO1992011867A1 (en) 1991-01-10 1991-12-13 Novel glucohydrolase inhibitors useful as antidiabetic agents

Publications (1)

Publication Number Publication Date
ES2136615T3 true ES2136615T3 (es) 1999-12-01

Family

ID=27093368

Family Applications (1)

Application Number Title Priority Date Filing Date
ES92904197T Expired - Lifetime ES2136615T3 (es) 1991-01-10 1991-12-13 Nuevos inhibidores de glucohidrolasa utiles como agentes antidiabeticos, antiviricos y antimetastasicos.

Country Status (15)

Country Link
US (1) US5438069A (es)
EP (1) EP0566666B1 (es)
JP (1) JP2951723B2 (es)
KR (1) KR100192862B1 (es)
AT (1) ATE183100T1 (es)
AU (1) AU660641B2 (es)
CA (1) CA2098927A1 (es)
DE (1) DE69131522T2 (es)
DK (1) DK0566666T3 (es)
ES (1) ES2136615T3 (es)
GR (1) GR3031423T3 (es)
IE (1) IE920087A1 (es)
NZ (1) NZ241234A (es)
PT (1) PT100001B (es)
WO (1) WO1992011867A1 (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1987003903A1 (en) * 1985-12-23 1987-07-02 Fred Hutchinson Cancer Research Center Regulating retroviral replication, infection, and pathogenesis
US5650413A (en) * 1995-06-07 1997-07-22 Glycodesign Inc. Derivatives of swainsonine, processes for their preparation and their use as therapeutic agents
AU736668B2 (en) * 1996-10-01 2001-08-02 Glycodesign Inc. Novel 3, 5, and/or 6 substituted analogues of swainsonine, processes for their preparation and their use as therapeutic agents
CA2286766A1 (en) 1997-04-15 1998-10-22 Glycodesign Inc. Alkaloid halide salts of swainsonine and methods of use
US5998485A (en) * 1997-06-16 1999-12-07 Cedars-Sinai Medical Center Method for modulating immune response with inositol
WO1999021858A1 (en) * 1997-10-24 1999-05-06 Glycodesign Inc. Synthesis of swainsonine salts

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4205068A (en) * 1978-05-18 1980-05-27 E. R. Squibb & Sons, Inc. β-Lactamase inhibitor EM4615
EP0056194B1 (en) * 1981-01-05 1984-09-12 Takeda Chemical Industries, Ltd. N-substituted pseudo-aminosugars, their production and use
US4399224A (en) * 1981-07-13 1983-08-16 A. E. Staley Manufacturing Company Enzymatically treated phosphatides
US4595678A (en) * 1982-03-19 1986-06-17 Takeda Chemical Industries, Ltd. N-substituted pseudo-aminosugars and pharmaceutical compositions containing same
US4622295A (en) * 1982-09-16 1986-11-11 Wako Pure Chemical Industries, Ltd. Modified oligosaccharides used as substrate for measuring α-amylase activity
ES2058070T3 (es) * 1986-05-09 1994-11-01 Pulverer Gerhard Utilizacion de monosacaridos especificos para la preparacion de un medicamento para impedir metastasis de tumores malignos.
US4963479A (en) * 1986-10-07 1990-10-16 Hoechst Celanese Corporation Reagent system for an alpha-amylase assay containing aromatic substituted glycoside
US4962097A (en) * 1988-10-28 1990-10-09 Merck & Co., Inc. Method of treating bacterial infection with phosphorus containing DHP enzyme inhibitors
US5032505A (en) * 1988-11-21 1991-07-16 Chembiomed, Ltd. Inhibitors for glycosaminosyl transferase V
US4988682A (en) * 1989-02-03 1991-01-29 University Of Pittsburgh Myo-inositol analogs and method for their use
US5053399A (en) * 1989-02-03 1991-10-01 University Of Pittsburgh Myo-inositol analogs and methods for their use
US5240707A (en) * 1990-04-12 1993-08-31 Merrell Dow Pharma Alpha-mannosidase and fucosidase inhibitors

Also Published As

Publication number Publication date
EP0566666B1 (en) 1999-08-11
JPH06504550A (ja) 1994-05-26
IE920087A1 (en) 1992-07-15
NZ241234A (en) 1994-07-26
PT100001A (pt) 1993-02-26
AU660641B2 (en) 1995-07-06
WO1992011867A1 (en) 1992-07-23
PT100001B (pt) 1999-06-30
JP2951723B2 (ja) 1999-09-20
GR3031423T3 (en) 2000-01-31
ATE183100T1 (de) 1999-08-15
DE69131522D1 (de) 1999-09-16
AU9176091A (en) 1992-08-17
EP0566666A4 (en) 1994-06-08
KR100192862B1 (ko) 1999-06-15
EP0566666A1 (en) 1993-10-27
KR930703013A (ko) 1993-11-29
DE69131522T2 (de) 1999-11-25
CA2098927A1 (en) 1992-07-11
DK0566666T3 (da) 1999-12-06
US5438069A (en) 1995-08-01

Similar Documents

Publication Publication Date Title
DE69115280T2 (de) Indolderivate, die die leukotrienbiosynthese hemmen.
ATE233561T1 (de) Imidazolverbindungen
GB2270075B (en) Substituted 2-phenyl-3-methoxypropenoate fungicides
ATE187732T1 (de) Hydrophile metallkomplexe
NO970162L (no) Substituerte pyrimidinforbindelser og anvendelse derav
DK0724435T3 (da) Amidinoderivater, der er nyttige som nitrogenoxid-synthase-inhibitorer
ATE194325T1 (de) Insektizide düngemischungen
DK0937074T3 (da) Benzonaphthyridiner som bronkiale terapeutiske midler
PT920426E (pt) Novos derivados de tiazole com efeito inibidor de fosfodiesterase
FI973221A0 (fi) 1-aryyli-2-asyyliammo-etaaniyhdisteitä ja niiden käyttö neurokiniiniantagonisteina, erityisesti neurokiniini 1 antagonisteina
DK0824350T3 (da) Anvendelse af et antimykotikum
SE9802937D0 (sv) Novel compounds
ES2136615T3 (es) Nuevos inhibidores de glucohidrolasa utiles como agentes antidiabeticos, antiviricos y antimetastasicos.
FI970330A0 (fi) Imidatsopyridiini-atsolidinonit
FR2707990B1 (fr) Nouvelles nitrones utilisables pour le piégeage des radicaux libres.
ES2147282T3 (es) Utilizacion de al menos un carburo terpenico y/o uno de sus derivados como adyuvante de un caldo herbicida o coformulante de una composicion herbicida
ES2091039T3 (es) Nuevos bis-fenil-hexenos.
SE9404438D0 (sv) New process
ECSP972052A (es) Quinoxalinadionas
UY24784A1 (es) Nuevos compuestos de imidazol sustituidos

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 566666

Country of ref document: ES